| |
| |
|
| Insider
Information: |
Chai Christopher Y |
| Relationship: |
Director |
| City: |
Mountain View |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
35,129 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$17,565 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
35,129 |
|
|
| Total
Value |
$17,565 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Map Pharmaceuticals Inc |
MAPP |
SVP, Chief Financial O... |
2013-03-01 |
0 |
2009-02-09 |
0 |
Premium* |
|
|
Principia Biopharma Inc |
PRNB |
Chief Financial Officer |
2020-09-28 |
0 |
2020-09-28 |
0 |
Premium* |
|
|
Surrozen Ord Shs |
SRZN |
Director |
2021-08-11 |
35,129 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SRZN |
Surrozen Ord Shs |
Director |
– • – |
2021-08-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
35,129 |
|
% |
|
| PRNB |
Principia Biopharma Inc |
Chief Financial Officer |
• – – |
2020-09-28 |
4 |
D |
$100.00 |
$330,200 |
I/I |
(3,302) |
0 |
0 |
- |
|
| PRNB |
Principia Biopharma Inc |
Chief Financial Officer |
• – – |
2020-09-28 |
4 |
D |
$100.00 |
$379,900 |
D/D |
(3,799) |
0 |
0 |
- |
|
| PRNB |
Principia Biopharma Inc |
Chief Financial Officer |
• – – |
2020-08-18 |
4 |
AS |
$99.37 |
$745,240 |
D/D |
(7,500) |
3,539 |
0 |
% |
|
| PRNB |
Principia Biopharma Inc |
Chief Financial Officer |
• – – |
2020-08-18 |
4 |
OE |
$3.00 |
$22,483 |
D/D |
7,500 |
11,039 |
0 |
- |
|
| PRNB |
Principia Biopharma Inc |
Chief Financial Officer |
• – – |
2020-05-19 |
4 |
OE |
$3.00 |
$17,012 |
D/D |
5,675 |
11,039 |
0 |
- |
|
| PRNB |
Principia Biopharma Inc |
Chief Financial Officer |
• – – |
2020-05-19 |
4 |
AS |
$65.10 |
$488,268 |
D/D |
(7,500) |
3,539 |
0 |
% |
|
| PRNB |
Principia Biopharma Inc |
Chief Financial Officer |
• – – |
2020-02-18 |
4 |
AS |
$63.86 |
$494,186 |
D/D |
(7,500) |
4,766 |
0 |
% |
|
| PRNB |
Principia Biopharma Inc |
Chief Financial Officer |
• – – |
2020-02-18 |
4 |
OE |
$3.00 |
$7,494 |
D/D |
2,500 |
12,266 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
SVP, Chief Financial Officer |
• – – |
2013-03-01 |
4 |
D |
$25.00 |
$355,500 |
D/D |
(14,220) |
0 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
SVP, Chief Financial Officer |
• – – |
2013-01-26 |
4 |
D |
$24.75 |
$21,607 |
D/D |
(873) |
13,899 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
SVP, Chief Financial Officer |
• – – |
2013-01-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,250 |
14,772 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
SVP, Chief Financial Officer |
• – – |
2013-01-25 |
4 |
D |
$24.75 |
$29,873 |
D/D |
(1,207) |
12,522 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
SVP, Chief Financial Officer |
• – – |
2013-01-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,750 |
13,729 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
SVP & CFO |
• – – |
2012-11-20 |
5 |
A |
$9.89 |
$5,501 |
D/D |
556 |
10,979 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
SVP & CFO |
• – – |
2012-05-20 |
5 |
A |
$9.81 |
$5,424 |
D/D |
553 |
10,423 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
SVP & CFO |
• – – |
2012-01-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,250 |
10,813 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
SVP & CFO |
• – – |
2012-01-26 |
4 |
D |
$13.84 |
$13,051 |
D/D |
(943) |
9,870 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
SVP & CFO |
• – – |
2011-11-20 |
5 |
A |
$11.54 |
$5,252 |
D/D |
455 |
8,563 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2011-09-20 |
4 |
AS |
$15.38 |
$492,278 |
D/D |
(32,000) |
7,703 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2011-09-20 |
4 |
OE |
$0.74 |
$23,789 |
D/D |
32,000 |
39,703 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
SVP & CFO |
• – – |
2011-05-20 |
5 |
A |
$12.65 |
$5,122 |
D/D |
405 |
8,108 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2010-11-20 |
5 |
A |
$12.50 |
$4,811 |
D/D |
385 |
7,703 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2010-09-20 |
4 |
AS |
$14.05 |
$224,808 |
D/D |
(16,000) |
6,709 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2010-09-20 |
4 |
OE |
$0.74 |
$11,894 |
D/D |
16,000 |
22,709 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
